Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines by Colombo GL, Matteo SD, Antinori A, Medaglia M, Murachelli S, Rizzardini G

Get full text

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatm... by Restelli U, Rizzardini G, Antinori A, Lazzarin A, Bonfanti M, Bonfanti P, Croce D

Get full text

Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy by Rizzardini G, Bonfanti P, Carenzi L, Coen M, Orlando G, Di Matteo S, Colombo GL

Get full text

Organisational and financial consequences of the early discharge of patients treated for acute bacterial skin and skin structure infection and osteomyelitis in infectious disease d... by Restelli, U, Bonfanti, M, Croce, D, Grau, S, Metallidis, S, Moreno Guillén, S, Pacelli, V, Rizzardini, G, Soro, M, Vozikis, A, Gray, A

Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort by Tontodonati M, Cenderello G, Celesia BM, Trezzi M, Ursini T, Costantini A, Marra D, Polilli E, Catalani C, Butini L, Sozio F, Mazzotta E, Sciacca A, Rizzardini G, Manzoli L, Cozzi-Lepri A, Parruti G

Get full text